Form 4 holding
Officer title: SVP Global Clinical Operations and Patient Advocacy
SOLENO THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 18 May 2026
- Price
- $33.48
- Ownership
- Direct